MedPath

A randomized controlled trial to assess feasibility and practicability of oatmeal intervention in metabolic impaired patients with diabetes mellitus type 2: a pilot study in the outpatient sector

Not Applicable
Conditions
Diabetes mellitus type 2
E11
Type 2 diabetes mellitus
Registration Number
DRKS00033580
Lead Sponsor
niversitätsklinikum Jena
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
17
Inclusion Criteria

Diabetes mellitus type 2, insulin-treated
- HbA1c > 7.5% (58 mmol/mol)
from October 2022 (amendment): HbA1c > 7.0% (53 mmol/mol)
- Insulin resistance (= 1 insulin unit / kg body weight)
- Independent lifestyle
- German language in written and spoken form
- Signed consent to participate in the study

Exclusion Criteria

- Implementation of an intervention in the 12 months prior to the start of the study that corresponds to the approach of this study
- Depression
- Eating disorder
- Pregnancy/breastfeeding
- Cardiac arrhythmia
- Dementia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility (> 70% of study cohort being successful) and practicability (assessed by protocol regarding performance aspects of intervention)
Secondary Outcome Measures
NameTimeMethod
Glycemic control (insulin doage, HbA1c, body weight, frequency of hypoglcemia) as well as treatment satisfaction (DTSQ-Questionnaire) and State of Health (EQ-5D-Questionnaire)
© Copyright 2025. All Rights Reserved by MedPath